BIOMAT Database Logo BIOMAT Database Logo

Anthranilic acid-based diamides derivatives incorporating aryl-isoxazoline pharmacophore as potential anticancer agents: design, synthesis and biological evaluation. 2012

Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
National Biopesticide Engineering Research Center, Hubei Academy of Agricultural Sciences, No. 8, Nanhu Avenue, Wuhan 430064, PR China.

A series of novel anthranilic diamides derivatives containing aryl-isoxazoline moiety were designed and synthesized as a part of our ongoing search for potential anticancer agents. Their structures were confirmed by (1)H NMR, (13)C NMR and ESI-MS analyses. The preliminary assays showed that some of the compounds displayed moderate to good antitumor activities against human lung cancer (NCI-H460), hepatocellular liver carcinoma (HepG2), gastric cancer (SGC-7901 and BGC-823) and breast epithelial adenocarcinoma (MCF-7) cell lines at μM level, which might be developed as novel lead scaffold for potential anticancer agents.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D003958 Diamide A sulfhydryl reagent which oxidizes sulfhydryl groups to the disulfide form. It is a radiation-sensitizing agent of anoxic bacterial and mammalian cells. Diazodicarboxylic Acid Bis(N,N-dimethyl)amide,Diazodicarboxylic Acid Bisdimethylamide,Dizene Dicarboxylic Acid Bis(N,N-dimethylamide),Dizenedicarboxylic Acid Bis(N,N-dimethylamide),Tetramethylazoformamide,Acid Bisdimethylamide, Diazodicarboxylic,Bisdimethylamide, Diazodicarboxylic Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D062367 ortho-Aminobenzoates Benzoic acids, salts, or esters that contain an amino group attached to carbon number 2 or 6 of the benzene ring structure. 2-Aminobenzoates,6-Aminobenzoates,Anthranilates,Anthranilic Acids,o-Aminobenzoates,o-Aminobenzoic Acids,ortho-Aminobenzoic Acids,6 Aminobenzoates,Acids, Anthranilic,Acids, o-Aminobenzoic,Acids, ortho-Aminobenzoic,o Aminobenzoates,o Aminobenzoic Acids,ortho Aminobenzoates,ortho Aminobenzoic Acids
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Nicotinamide-based diamides derivatives as potential cytotoxic agents: synthesis and biological evaluation.
October 2017, Chemistry Central journal,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Anthranilic diamides derivatives as potential ryanodine receptor modulators: Synthesis, biological evaluation and structure activity relationship.
July 2018, Bioorganic & medicinal chemistry,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
February 2018, Bioorganic & medicinal chemistry letters,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis and biological evaluation of 3,5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents.
September 2010, European journal of medicinal chemistry,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
September 2013, Bioorganic & medicinal chemistry letters,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis and biological evaluation of novel bromophenol derivatives incorporating indolin-2-one moiety as potential anticancer agents.
February 2015, Marine drugs,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents.
December 2018, Natural product research,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents.
June 2021, Bioorganic chemistry,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
New potential anticancer agents based on the anthranilic acid scaffold: synthesis and evaluation of biological activity.
December 2005, Journal of medicinal chemistry,
Liqiao Shi, and Rui Hu, and Yanhong Wei, and Ying Liang, and Ziwen Yang, and Shaoyong Ke
Design, synthesis, and biological evaluation of new arjunolic acid derivatives as anticancer agents.
February 2023, RSC medicinal chemistry,
Copied contents to your clipboard!